Cardiogram raises $2 million for app that could detect atrial fibrillation, diabetes
Cardiogram, a health tech startup in San Francisco, has raised $2 million to develop an app that shows a user’s cardio health while providing tips on how to improve and maintain a healthy heart.
The fundraising was led by a16z Bio Fund, a venture capital firm in Menlo Park, California. Other investors include Homebre and Color Genomics.
Cardiogram was originally an app specifically designed to integrate with the Apple Watch, but the company has plans to expand it so it’s compatible with Android, Fitbit and Garmin devices.
“Cardiogram is doing something I’m excited about in general, which is taking massive quantities of data from new sources, in their case from wearables…and applying state of the art machine learning techniques to it so that people can gain something from it on their own,” said Vijay Pande, a general partner at a16z, in an interview with Tech Crunch.
The app, used by people age 18 to 94, will soon be able to identify and predict when a user has or is developing atrial fibrillation or diabetes. Cardiogram’s founders are working with researchers and cardiologists at the University of California, San Francisco to create those features.
Senior Writer
As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.